Sumanta K. Pal: I’m hugely indebted to Matt Galsky, not just for the chance to be a part of this Nature Medicine masterpiece he drove, but to see the joy of my pts doing well years out from chemo/IO without cystectomy.

Sumanta K. Pal, Professor and Co-director of City of Hope’s Kidney Cancer Program, shared a post on X/Twitter:

”I’m hugely indebted to Matt Galsky, not just for the chance to be a part of this Nature Medicine masterpiece he drove, but to see the joy of my pts doing well years out from chemo/IO w/o cystectomy. But not the 1st time Matt has given my pts a gift via our collaboration.
Matt is a visionary. Our 1st (2nd?) collab was on a trial of cis/gem+ipi for mUC. I met a pt in 2014 (well before CPI was SOC) with bowel obstruction from UC; started on Matt’s study & doing brilliantly p 9y. Matt published a biological interrogation of responders in the Journal for ImmunoTherapy of Cancer.
My note to GU oncologist colleagues: If there’s an opportunity to participate in trials proposed by Matt Galsky, take it! The advice I gave to our City of Hope, bladder cancer lead Abhishek Tripathi, who is now enrolling to Matt Galsky‘s neoadjuvant pembrolizumab study. Keep up the amazing work, Matt! ”

For the article click here.
Source: Sumanta K. Pal/Twitter